Genetic basis of atherosclerosis: Part II - Clinical implications

被引：66

作者：

Lusis, AJ

Fogelman, AM

Fonarow, GC

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Div Cardiol, Los Angeles, CA USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA

来源：

CIRCULATION | 2004年 / 110卷 / 14期

关键词：

atherosclerosis; diagnosis; genetics; lipoproteins; prevention;

D O I：

10.1161/01.CIR.0000143098.98869.F8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2066 / 2071

页数：6

共 33 条

[1]

BERG K, 1989, CLIN GENET, V36, P299

[2] APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS [J].

BOERWINKLE, E ;

LEFFERT, CC ;

LIN, JP ;

LACKNER, C ;

CHIESA, G ;

HOBBS, HH .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :52-60

[3] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].

BROWN, MS ;

GOLDSTEIN, JL .

SCIENCE, 1986, 232 (4746) :34-47

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[5] Hepatic lipase: new insights from genetic and metabolic studies [J].

Cohen, JC ;

Vega, GL ;

Grundy, SM .

CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) :259-267

[6] Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis [J].

de Maat, MPM ;

Jukema, JW ;

Ye, S ;

Zwinderman, AH ;

Moghaddam, PH ;

Beekman, M ;

Kastelein, JJP ;

van Boven, AJ ;

Bruschke, AVG ;

Humphries, SE ;

Kluft, C ;

Henney, AM .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (06) :852-856

[7] Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment [J].

Drazen, JM ;

Yandava, CN ;

Dubé, L ;

Szczerback, N ;

Hippensteel, R ;

Pillari, A ;

Israel, E ;

Schork, N ;

Silverman, ES ;

Katz, DA ;

Drajesk, J .

NATURE GENETICS, 1999, 22 (02) :168-170

[8] Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis [J].

Dwyer, JH ;

Allayee, H ;

Dwyer, KM ;

Fan, J ;

Wu, HY ;

Mar, R ;

Lusis, AJ ;

Mehrabian, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) :29-37

[9] A-IMILANO APOPROTEIN - DECREASED HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS WITH SIGNIFICANT LIPOPROTEIN MODIFICATIONS AND WITHOUT CLINICAL ATHEROSCLEROSIS IN AN ITALIAN FAMILY [J].

FRANCESCHINI, G ;

SIRTORI, CR ;

CAPURSO, A ;

WEISGRABER, KH ;

MAHLEY, RW .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (05) :892-900

[10] Lipoprotein lipase is a gene for insulin resistance in Mexican Americans [J].

Goodarzi, MO ;

Guo, XQ ;

Taylor, KD ;

Quiñones, MJ ;

Saad, MF ;

Yang, HY ;

Hsueh, WA ;

Rotter, JI .

DIABETES, 2004, 53 (01) :214-220

← 1 2 3 4 →